Natalie De Ruyck

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

Zhaofeng Xu (UGent) , Yanran Huang (UGent) , Tim Meese (UGent) , Sharon Van Nevel (UGent) , Gabriële Holtappels (UGent) , Stijn Vanhee (UGent) , Barbara M. Bröker, Zhengqi Li, Ellen De Meester (UGent) , Natalie De Ruyck (UGent) , et al.

(2023) CLINICAL IMMUNOLOGY. 256.

Add to list

Journal Article
A1
open access

Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

Olga Krysko (UGent) , Darya Korsakova, Andrea Renate Teufelberger, Amse De Meyer (UGent) , Jill Steels (UGent) , Natalie De Ruyck (UGent) , Judith van Ovost (UGent) , Sharon Van Nevel (UGent) , Gabriële Holtappels (UGent) , Frauke Coppieters (UGent) , et al.

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

Sharon Van Nevel (UGent) , Tim Meese (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Stijn Vanhee (UGent) , Nan Zhang (UGent) , Filip Van Nieuwerburgh (UGent) and Claus Bachert (UGent)

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187

Add to list

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Jozefien Declercq (UGent) , Els Tobback (UGent) , Stijn Vanhee (UGent) , Natalie De Ruyck (UGent) , Sarah Gerlo (UGent) , Philippe Gevaert (UGent) and Linos Vandekerckhove (UGent)

(2022) ALLERGY. 77(1). p.304-307

Add to list

Journal Article
A1
open access

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study

Philippe Gevaert (UGent) , Jarno De Craemer (UGent) , Natalie De Ruyck (UGent) , Sylvie Rottey (UGent) , Jan de Hoon, Peter W. Hellings, Bram Volckaert, Kristof Lesneuck, Jamie M. Orengo, Amanda Atanasio, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(1). p.189-199

Add to list

Journal Article
A1
open access

Neutrophils affect IL-33 processing in response to the respiratory allergen Alternaria alternata

Sharon Van Nevel (UGent) , Judith van Ovost (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Nan Zhang (UGent) , Harald Braun (UGent) , Tania Maes (UGent) , Claus Bachert (UGent) and Olga Krysko (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 12.

Add to list

A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps

Tim Delemarre (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Nan Zhang (UGent) , Hans Nauwynck (UGent) , Claus Bachert (UGent) and Elien Gevaert (UGent)

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.179-188.e2

Add to list

An underestimated predictive role for Type 2 inflammation in CRSsNP

Tim Delemarre (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Claus Bachert (UGent) and Elien Gevaert (UGent)

(2020) ALLERGY. In Allergy 75(Supplement 109). p.107-108

Add to list

Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation

Sharon Van Nevel (UGent) , Natalie De Ruyck (UGent) , Gabriële Holtappels (UGent) , Claus Bachert (UGent) and Olga Krysko (UGent)

(2020) ALLERGY. In Allergy 75(Suppl. 109). p.50-50

Add to list

Journal Article
A1
open access

Chronic rhinosinusitis : assessment of changes in nociceptive neurons

Stijn Bogaert, Koen Van Crombruggen (UGent) , Gabriële Holtappels (UGent) , Natalie De Ruyck (UGent) , Nicole Suchonos, Jonas Jae-Hyun Park and Claus Bachert (UGent)

(2020) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 10(10). p.1165-1172

Academic Bibliography

Natalie De Ruyck

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study

Neutrophils affect IL-33 processing in response to the respiratory allergen Alternaria alternata

A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps

An underestimated predictive role for Type 2 inflammation in CRSsNP

Differential response of C57BL/6 and BALB/c mice in Alternaria alternata-induced allergic airway inflammation

Chronic rhinosinusitis : assessment of changes in nociceptive neurons

Contents

Support

Contact